ZOTA Zota Health Care Q1 FY26 results (Apr–Jun 2025) and concall
Zota Health Care reported strong Q1 FY26 results, with consolidated revenue growing 84% YoY to INR 103.58 crores, driven by a 111% surge in DavaIndia's contribution. The company achieved a positive EBITDA of INR 4.83 crores (4.7% margin), a turnaround from a loss in the prior year. Store expansion continued aggressively, with 163 new DavaIndia stores added, bringing the total network to 1,745. Management expressed confidence in achieving full-year store targets and sustained profitability as stores mature.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 59 | 68 | 78 | 78 |
| EBITDA | 3 | 1 | 4 | 7 |
| Net profit | 2 | 2 | 3 | 6 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
